Announcement no. 3/2008
To the OMX Nordic Exchange
Copenhagen,
January 22, 2008
Major Shareholder Announcement
§29 announcement from Lønmodtagernes Dyrtidsfond - appendix attached (only in
Danish)
Yours sincerely,
Curalogic A/S
For additional information, please contact:
Peter Moldt, President and CEO, Phone +45 99 99 24 00, mobile +45 26 25 04 22
Helle Busck Fensvig, EVP and CFO, Phone +45 99 99 24 00, mobile +45 20 70 55 37
About Curalogic
Curalogic is a Danish biopharmaceutical company listed on the OMX Nordic
Exchange (CUR.CO) as a SmallCap+ company. Curalogic has ample cash resources and
has demonstrated its ability to conduct complex clinical studies with a small
group of development experts.
This announcement contains forward-looking statements regarding the Company's
future financial development and performance and other statements which are not
historical facts. Such statements are made on the basis of assumptions and
expectations which, to the best of the Company's knowledge and belief, are
reasonable, at this time, but may prove to be erroneous in the future.
